Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes

Systemically administered glucocorticoids constitute an essential part of the immunosuppressive regimen for transplant recipients, yet their known risks of causing hyperglycemia or posttransplant diabetes require close monitoring and minimisation of use, when possible, to prevent detrimental effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Bøtker, Simon, Birn, Henrik, Øzbay, Lara Aygen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884167/
https://www.ncbi.nlm.nih.gov/pubmed/36718481
http://dx.doi.org/10.1155/2023/3648178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884167/
https://www.ncbi.nlm.nih.gov/pubmed/36718481
http://dx.doi.org/10.1155/2023/3648178

Ejemplares similares